Protective Effect of Higher Free Thyroxine Levels Within the Reference Range on Biliary Tract Cancer Risk: a Multivariable Mendelian Randomization and Mediation Analysis

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Apr 30

PMID 38686204

Authors

Yuxian Chen

Hao Dong

Baozhen Qu

Xuezhen Ma

Linlin Lu

Affiliations

Soon will be listed here.

Abstract

Background: Hepatobiliary cancer (HBC), including hepatocellular carcinoma (HCC) and biliary tract cancer (BTC), is currently one of the malignant tumors that mainly cause human death. Many HBCs are diagnosed in the late stage, which increases the disease burden, indicating that effective prevention strategies and identification of risk factors are urgent. Many studies have reported the role of thyroid hormones on HBC. Our research aims to assess the causal effects and investigate the mediation effects between thyroid function and HBC.

Methods: Utilizing the Mendelian randomization (MR) approach, the study employs single nucleotide polymorphisms (SNPs) as instrumental variables (IVs) to explore causal links between thyroid function [free thyroxine (FT4), thyroid stimulating hormone (TSH), hyperthyroidism and hypothyroidism] and HBC. Data were sourced from the ThyroidOmic consortium and FinnGen consortium. The analysis included univariable and multivariable MR analysis, followed by mediation analysis.

Results: The study found a significant causal association between high FT4 levels and the reduced risk of BTC, but not HCC. However, TSH, hyperthyroidism and hypothyroidism had no causal associations with the risk of HBC. Notably, we also demonstrated that only higher FT4 levels with the reference range (FT4-RR) could reduce the risk of BTC because this protective effect no longer existed under the conditions of hyperthyroidism or hypothyroidism. Finally, we found that the protective effect of FT4-RR on BTC was mediated partially by decreasing the risk of metabolic syndrome (MetS) and reducing the waist circumference (WC).

Conclusion: The findings suggest that higher FT4-RR may have a protective effect against BTC, which is partially mediated by decreased risk of MetS and a reduction in WC. This study highlights the potential role of FT4 in the pathogenesis of BTC and underscores that MetS and WC may play mediation effects as two mediators in this process.

Citing Articles

Causal Effects and Immune Cell Mediators of Prescription Analgesic Use and Risk of Liver Cancer and Precancerosis in European Population: A Mendelian Randomization Study.

Tao X, Mao S, Wang J, Li G, Sun B Biomedicines. 2024; 12(7).

PMID: 39062110 PMC: 11274554. DOI: 10.3390/biomedicines12071537.

References

Slob E, Burgess S . A comparison of robust Mendelian randomization methods using summary data. Genet Epidemiol. 2020; 44(4):313-329. PMC: 7317850. DOI: 10.1002/gepi.22295. View

Lawlor D, Harbord R, Sterne J, Timpson N, Davey Smith G . Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2007; 27(8):1133-63. DOI: 10.1002/sim.3034. View

Kim E, Chang Y, Lee K, Yun J, Park Y, Park C . Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk: A cohort study. Int J Cancer. 2019; 145(12):3257-3266. DOI: 10.1002/ijc.32283. View

Cavallo A, Priore P, Gnoni G, Papa S, Zanotti F, Gnoni A . 3,5-Diiodo-L-thyronine administration to hypothyroid rats rapidly enhances fatty acid oxidation rate and bioenergetic parameters in liver cells. PLoS One. 2013; 8(1):e52328. PMC: 3537720. DOI: 10.1371/journal.pone.0052328. View

Moeller L, Fuhrer D . Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective. Endocr Relat Cancer. 2013; 20(2):R19-29. DOI: 10.1530/ERC-12-0219. View

Chan I, Privalsky M . Thyroid hormone receptor mutants implicated in human hepatocellular carcinoma display an altered target gene repertoire. Oncogene. 2009; 28(47):4162-74. PMC: 2787677. DOI: 10.1038/onc.2009.265. View

Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan N, Thompson J . A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017; 36(11):1783-1802. PMC: 5434863. DOI: 10.1002/sim.7221. View

Yen C, Huang Y, Liao C, Liao C, Cheng W, Chen W . Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta. J Mol Endocrinol. 2006; 36(1):9-21. DOI: 10.1677/jme.1.01911. View

Yang B, Yang J, Wong M, Rana J, Yang Q, Chan V . Trends in elevated waist-to-height ratio and waist circumference in U.S. adults and their associations with cardiometabolic diseases and cancer, 1999-2018. Front Nutr. 2023; 10:1124468. PMC: 10126508. DOI: 10.3389/fnut.2023.1124468. View

10.

Recalde M, Davila-Batista V, Diaz Y, Leitzmann M, Romieu I, Freisling H . Body mass index and waist circumference in relation to the risk of 26 types of cancer: a prospective cohort study of 3.5 million adults in Spain. BMC Med. 2021; 19(1):10. PMC: 7807518. DOI: 10.1186/s12916-020-01877-3. View

11.

Reddy A, Dash C, Leerapun A, Mettler T, Stadheim L, Lazaridis K . Hypothyroidism: a possible risk factor for liver cancer in patients with no known underlying cause of liver disease. Clin Gastroenterol Hepatol. 2006; 5(1):118-23. DOI: 10.1016/j.cgh.2006.07.011. View

12.

Garcia-Silva S, Martinez-Iglesias O, Ruiz-Llorente L, Aranda A . Thyroid hormone receptor β1 domains responsible for the antagonism with the ras oncogene: role of corepressors. Oncogene. 2010; 30(7):854-64. DOI: 10.1038/onc.2010.464. View

13.

Cavallo A, Gnoni A, Conte E, Siculella L, Zanotti F, Papa S . 3,5-diiodo-L-thyronine increases FoF1-ATP synthase activity and cardiolipin level in liver mitochondria of hypothyroid rats. J Bioenerg Biomembr. 2011; 43(4):349-57. DOI: 10.1007/s10863-011-9366-3. View

14.

Jun J, Jee J, Bae J, Jin S, Hur K, Lee M . Association Between Changes in Thyroid Hormones and Incident Type 2 Diabetes: A Seven-Year Longitudinal Study. Thyroid. 2016; 27(1):29-38. DOI: 10.1089/thy.2016.0171. View

15.

Gionfra F, De Vito P, Pallottini V, Lin H, Davis P, Pedersen J . The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer. Front Endocrinol (Lausanne). 2019; 10:532. PMC: 6730500. DOI: 10.3389/fendo.2019.00532. View

16.

Zvibel I, Atias D, Phillips A, Halpern Z, Oren R . Thyroid hormones induce activation of rat hepatic stellate cells through increased expression of p75 neurotrophin receptor and direct activation of Rho. Lab Invest. 2010; 90(5):674-84. DOI: 10.1038/labinvest.2010.48. View

17.

Davey Smith G, Ebrahim S . 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol. 2003; 32(1):1-22. DOI: 10.1093/ije/dyg070. View

18.

Vitale A, Svegliati-Baroni G, Ortolani A, Cucco M, Dalla Riva G, Giannini E . Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database. Gut. 2021; 72(1):141-152. DOI: 10.1136/gutjnl-2021-324915. View

19.

Kondo T, Ezzat S, Asa S . Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer. 2006; 6(4):292-306. DOI: 10.1038/nrc1836. View

20.

Yao K, Jabbour S, Parekh N, Lin Y, Moss R . Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database. BMC Gastroenterol. 2016; 16(1):117. PMC: 5031355. DOI: 10.1186/s12876-016-0527-z. View